Human placenta under DMF controls from July.

The crude human placenta for the use of drugs was classified as a bulk drug subjected to the DMF controls starting from July 1, which therefore causes for any human placenta drugs to fall under the KFDA's examination in its manufacture and quality according to the revised "guideline of bulk drug report".

Article 2 of the revised guideline designated "bulk drugs derived from human placenta" a...